Literature DB >> 20655867

Bone and bone marrow: the same organ.

Andrea Del Fattore1, Marta Capannolo, Nadia Rucci.   

Abstract

Interplays between bone and bone marrow are not limited to merely anatomic and histological connections, but include a tight functional correlation. Bone marrow resides within the medullary cavity of the bones and the process of hematopoiesis is regulated, at least in part, by bone cells. Moreover, osteoclasts and osteoblasts derive from precursors of hematopoietic and mesenchymal origin, respectively, both residing within the bone marrow. Alterations in one of these components typically cause impairment in the other, so diseases of the bone marrow compartment often affect the bone and vice versa. All these findings could make us to speculate that bone and bone marrow are not two separate districts, but can be considered as the two elements of the same unique functional unit, the bone-bone marrow organ. Here we will describe histological and functional interplays between bone and bone marrow, and will illustrate some diseases in which this tight correlation is evident.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20655867     DOI: 10.1016/j.abb.2010.07.020

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  13 in total

1.  The effects of rosiglitazone on osteoblastic differentiation, osteoclast formation and bone resorption.

Authors:  Eui-Sic Cho; Myoung-Kyun Kim; Young-Ok Son; Keun-Soo Lee; Seung-Moon Park; Jeong-Chae Lee
Journal:  Mol Cells       Date:  2012-02       Impact factor: 5.034

2.  Osteoclasts and hematopoiesis.

Authors:  Anna Teti
Journal:  Bonekey Rep       Date:  2012-03-28

Review 3.  Bone development: overview of bone cells and signaling.

Authors:  Anna Teti
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

4.  Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis.

Authors:  Valeria B Fernández Vallone; Erica L Hofer; Hosoon Choi; Raúl H Bordenave; Emilio Batagelj; Leonardo Feldman; Vincent La Russa; Daniela Caramutti; Federico Dimase; Vivian Labovsky; Leandro M Martínez; Norma A Chasseing
Journal:  Clin Exp Metastasis       Date:  2012-09-30       Impact factor: 5.150

5.  Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations.

Authors:  Marta Galán-Díez; Adiba Isa; Marco Ponzetti; Morten Frost Nielsen; Moustapha Kassem; Stavroula Kousteni
Journal:  Biochim Biophys Acta       Date:  2015-12-08

Review 6.  Osteopetrosis and its relevance for the discovery of new functions associated with the skeleton.

Authors:  Amélie E Coudert; Marie-Christine de Vernejoul; Maurizio Muraca; Andrea Del Fattore
Journal:  Int J Endocrinol       Date:  2015-03-19       Impact factor: 3.257

7.  Interleukin-35 Inhibits TNF-α-Induced Osteoclastogenesis and Promotes Apoptosis via Shifting the Activation From TNF Receptor-Associated Death Domain (TRADD)-TRAF2 to TRADD-Fas-Associated Death Domain by JAK1/STAT1.

Authors:  Mingzheng Peng; Yanguo Wang; Lei Qiang; Yan Xu; Cuidi Li; Tao Li; Xiaojun Zhou; Ming Xiao; Jinwu Wang
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

8.  Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.

Authors:  Seung-Youp Lee; Keun-Soo Lee; Sea Hyun Yi; Sung-Ho Kook; Jeong-Chae Lee
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

9.  A Lox/CHOP-10 crosstalk governs osteogenic and adipogenic cell fate by MSCs.

Authors:  Wen-Yan Jiang; Chun Xing; Hong-Wei Wang; Wei Wang; Su-Zhen Chen; Liu-Fang Ning; Xu Xu; Qi-Qun Tang; Hai-Yan Huang
Journal:  J Cell Mol Med       Date:  2018-07-25       Impact factor: 5.310

Review 10.  Cellular and Molecular Mediators of Bone Metastatic Lesions.

Authors:  Giulia Battafarano; Michela Rossi; Francesco Marampon; Andrea Del Fattore
Journal:  Int J Mol Sci       Date:  2018-06-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.